Description
Added on the 09/11/2020 11:13:27 - Copyright : Wochit
Pfizer’s experimental vaccine looks to be highly effective at preventing COVID-19. The effective rate sits right at 90% and there are no apparent safety problems, reports HuffPost. However, to be clear, this is all based on the company’s own preliminary data. The announcement got attention around the world, sending financial markets up on hopes. In the U.S., it set off an immediate political controversy regarding the Trump administration. Critics argued over how much credit if any Trump deserves for the apparent medical advancement.
Madrid, Nov 9 (EFECOM).- The Spanish stock market soared on Monday by 9.5% after the companies Pfizer and BioNTech said that their Covid-19 vaccine was 90% effective in tests.FOOTAGE OF MADRID STOCK EXCHANGE
New York (USA), Nov 9 (EFE / EPA), (Camera: Alba Vigaray).- US stocks rocketed on Monday after American pharmaceutical giant Pfizer announced that its candidate Covid-19 vaccine was 90% effective.FOOTAGE OF NEW YORK STOCK EXCHANGE
Pfizer's coronavirus vaccine candidate is more than 90% effective in preventing COVID-19. Other vaccines like chickenpox, measles, and polio all hover in the 90% and higher effective range. Pfizer and its German partner BioNTech made the announcement Monday, says Business Insider. The partnership is the first to report positive results from the final stage of clinical trials. The shot was found to prevent COVID-19 decently in the 94 study cases of the disease observed. The vaccine will most likely be given out in two doses spaced three weeks apart.
|
Support : Technical 
- Content 
- Editors 
